Boardroom Alpha
10-K primary document
INVA · Annual Report (Form 10-K) · Filed February 25, 2026

Innoviva Inc10-K exhibit

inva-ex21_1.htm
EX-21.1

 

Exhibit 21.1

 

LIST OF SUBSIDIARIES

 

Name

 

Jurisdiction

 

Ownership
Interest

Advanced Medicine East, Inc

 

Delaware

 

100%

Innoviva Strategic Partners LLC

 

Delaware

 

100%

Innoviva Royalty Sub LLC

 

Delaware

 

100%

Innoviva TRC Holdings LLC

 

Delaware

 

100%

Innoviva Strategic Opportunities LLC

 

Delaware

 

100%

ISP Fund LP

 

Delaware

 

100%

Innoviva Specialty Therapeutics Holdings LLC

 

Delaware

 

100%

Innoviva Specialty Therapeutics Inc.

 

Delaware

 

100%

ISTx, LLC

 

Delaware

 

100%

Entasis Therapeutics Holdings Inc.

 

Delaware

 

100%

Entasis Therapeutics Inc.

 

Delaware

 

100%

Entasis Therapeutics (Ireland) Limited

 

Ireland

 

100%

La Jolla Pharmaceutical Company

 

Delaware

 

100%

La Jolla Pharma, LLC

 

Delaware

 

100%

Tetraphase Pharmaceuticals, Inc.

 

Delaware

 

100%

La Jolla Pharmaceutical Holdings, LLC

 

Delaware

 

100%

Nortiva Bio, Inc.

 

Delaware

 

100%

 

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer